This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jul. 3, 2013


 



Surgeons report melanoma recurs after 10 years in more than 6 percent of patients
Journal of the American College of Surgeons
Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live longer after their cancer returns than patients whose melanoma recurs in the first three years.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Genome instability studies could change treatment for cancer, other diseases
Penn State News
Counterintuitive as it may seem, genetic mutation is key to our evolution and survival. As our cells grow, reproduce, and die, DNA is repeatedly replicated and repaired, and bits and pieces of its sequences are perpetually changed, misplaced, and swapped in the process, thus producing mutations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Heart failure tied to higher cancer risk
Reuters
People with heart failure are also more likely to be diagnosed with cancer, according to a new study that followed older adults with and without heart problems. The findings don't prove that heart failure — when the heart can't pump enough blood to the rest of the body — causes cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  By Popular Demand - View the Replay

Executives from AdvancedMD and MediGain share their expertise on how to be prepared for the changing landscape of healthcare.
  • ICD-10 - How to start preparing NOW!
  • The NEW Reimbursement Model
  • The Technology You Need to Comply and Thrive!
 


Drug action in pancreatic cancer tracked and improved by nanotechnology
Oncology Nurse Advisor
Tiny biosensors used with new advanced imaging techniques are markedly improving drug targeting of solid tumors, according to new research. These new technologies work in real time and in three dimensions. They can show how cancers spread and how active cancer cells respond to a particular drug.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Insulin link to pancreatic cancer
The Almagest
A study reveals that higher insulin, insulin resistance and diabetes are linked to an increased risk of pancreatic cancer. Previous evidence has suggested that diabetes and pancreatic cancer are associated. But it has not really been clear whether diabetes causes the cancer or whether it is the other way round.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertise here!

To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE


Colon cancer facts
Chicago Tribune
Colon cancer is also known as bowel cancer or colorectal cancer. It is the cancer that occurs in the large intestines, the lower part of the digestive system. It starts as a small polyp or clumps in the cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Azoospermic men face higher cancer risk
Healio
Infertile, azoospermic men are at a higher risk for cancer, according to study results. Prior genetic-based studies have indicated that male infertility is linked to cancer. Mutations in the Lynch syndrome gene MLH1 have been observed in men with azoospermia, and azoospermic mice deficient in ERCC1 and MSH2 have been shown to develop tumors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


AJCC calls for contributors to Cancer Staging Manual, 8th Edition
American Joint Committee on Cancer
The American Joint Committee on Cancer is seeking cancer professionals to collaborate on the development of the AJCC Cancer Staging Manual, 8th Edition.

A number of opportunities are available in two areas:
  • Disease Site Expert Panel: Members will research, write, review or otherwise contribute to chapter content.
  • Review Core: Members will provide expert review of all content in the areas of evidence-based medicine and statistics, precision medicine, cancer registry and surveillance and data harmonization.

    Access the application online. AJCC will not accept unsolicited curriculum vitaes. Only individuals who complete this application will be considered. The application period will close July 31. Contact ajcc@facs.org for more information.

  • Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Study: Aspirin benefit in colon cancer tied to gene variant
    Bloomberg Businessweek
    Aspirin's benefit in thwarting colon cancer is driven by a gene mutation that makes tumor cells less sensitive to the drug's effects, according to a study that may lead to personalized prevention strategies.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Biomarker predicts risk of breast cancer recurrence after tamoxifen treatment
    redOrbit
    A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE
    Looking for similar articles? Search here, keyword BREAST CANCER.


    Thyroid cancer — rising most rapidly among insured patients
    Dartmouth-Hitchcock Medical Center via EureakAlert!
    The rapid increase in papillary thyroid cancer in the U.S. may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center. Instead it may be linked to an increase in the diagnosis of precancerous conditions and to a person's insurance status.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    How the body aids and abets the spread of cancer
    Science Codex
    The very system that is meant to protect the body from invasion may be a traitor. These new findings of a study reveal that infection-fighting white blood cells play a role in activating cancer cells and facilitating their spread to secondary tumors.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE
     




    The CoC Brief

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Andrew Plock, Content Editor, 469.420.2609  
    Contribute news

    Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


    Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

    This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

    Recent issues

    June 26, 2013
    June 19, 2013
    June 12, 2013
    June 5, 2013






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063